Dystroglycan is able to translocate to the nucleus in the androgen-independent prostate cell lines PC3 and DU145 (see supplementary figure 4 in reference13), demonstrating that dystroglycan translocation to the nucleus in prostate cancer cells is not necessarily part of the androgen response mechanism driven through the androgen receptor. The gene discussed is DAG1; the disease is Familial prostate cancer.